Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2201]

FDA approves isatuximab-irfc for multiple myeloma

FDA approves isatuximab-irfc for multiple myeloma

High thrombotic risk in cancer patients receiving immunotherapy

High thrombotic risk in cancer patients receiving immunotherapy

FDA approves idecabtagene vicleucel for multiple myeloma

FDA approves idecabtagene vicleucel for multiple myeloma

Percutaneous image guided thermal ablation safe, effective therapy for metastatic gynaecologic cancers

Percutaneous image guided thermal ablation safe, effective therapy for metastatic gynaecologic cancers

NICE recommends carfilzomib with lenalidomide and dexamethasone for previously treated multiple myeloma

NICE recommends carfilzomib with lenalidomide and dexamethasone for previously treated multiple myeloma

Researchers use machine learning to rank cancer drugs in order of efficacy

Researchers use machine learning to rank cancer drugs in order of efficacy

Prostate cancer uses metabolic switch to thrive after hormone therapy

Prostate cancer uses metabolic switch to thrive after hormone therapy

Study finds high tumour mutation burden predicts immunotherapy response in some, but not all, cancers

Study finds high tumour mutation burden predicts immunotherapy response in some, but not all, cancers

$FDA approves tivozanib for relapsed or refractory advanced renal cell carcinoma$

FDA approves tivozanib for relapsed or refractory advanced renal cell carcinoma

Conquering cancer: Global strategy for the elimination of cervical cancer

Conquering cancer: Global strategy for the elimination of cervical cancer

More from ecancer